BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18375356)

  • 1. Development and progression of colorectal neoplasia.
    Manne U; Shanmugam C; Katkoori VR; Bumpers HL; Grizzle WE
    Cancer Biomark; 2010; 9(1-6):235-65. PubMed ID: 22112479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.
    Wu H; Liu J; Yin Y; Zhang D; Xia P; Zhu G
    Biomed Res Int; 2019; 2019():9740568. PubMed ID: 31637261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contributions of molecular biology to the management of colorectal cancer].
    Grancher A; Cuissy S; Sefrioui D; Di Fiore F
    Rev Prat; 2024 Apr; 74(4):355-358. PubMed ID: 38814021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors.
    Heiser CN; Simmons AJ; Revetta F; McKinley ET; Ramirez-Solano MA; Wang J; Kaur H; Shao J; Ayers GD; Wang Y; Glass SE; Tasneem N; Chen Z; Qin Y; Kim W; Rolong A; Chen B; Vega PN; Drewes JL; Markham NO; Saleh N; Nikolos F; Vandekar S; Jones AL; Washington MK; Roland JT; Chan KS; Schürpf T; Sears CL; Liu Q; Shrubsole MJ; Coffey RJ; Lau KS
    Cell; 2023 Dec; 186(25):5620-5637.e16. PubMed ID: 38065082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genomic characteristics of metabolic syndrome in colorectal cancer.
    Li Y; Zhao J; Wu X; Zhang Y; Jin Y; Cai W
    Aging (Albany NY); 2021 Feb; 13(4):5442-5460. PubMed ID: 33582655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular senescence: a promising therapeutic target in colorectal cancer.
    Wu Y; Xie M; Sun JH; Li CC; Dong GH; Zhang QS; Cui PL
    Future Oncol; 2022 Sep; 18(30):3463-3470. PubMed ID: 36069254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of chemically induced rodent models for sporadic colorectal cancer: Histopathological and translational perspectives.
    Sarmiento-Machado LM; Rodrigues MAM; Romualdo GR; Barbisan LF
    Histol Histopathol; 2024 Jun; 39(6):691-702. PubMed ID: 38179656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptides against colorectal cancer-a focused review.
    Chauhan S; Dhawan DK; Saini A; Preet S
    Pharmacol Res; 2021 May; 167():105529. PubMed ID: 33675962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Colorectal Cancer from Ethology to Interdisciplinary Treatment: The Gains and Challenges of Modern Medicine.
    Berbecka M; Berbecki M; Gliwa AM; Szewc M; Sitarz R
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapies.
    Wolf D; Salcher S; Pircher A
    J Clin Invest; 2024 Mar; 134(5):. PubMed ID: 38426495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Sides of the Same Coin: The Roles of Transforming Growth Factor-β in Colorectal Carcinogenesis.
    Feng Y; Pauklin S
    Gastroenterology; 2020 Jul; 159(1):397-398. PubMed ID: 32234301
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond Time and Space: Charting Dynamic Evolution of Sporadic Colorectal Cancer.
    Lombardi P; Pinato DJ
    Gastroenterology; 2024 May; 166(5):937-938. PubMed ID: 38340871
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.
    Martí J; Fuster J; Solà AM; Hotter G; Molina R; Pelegrina A; Ferrer J; Deulofeu R; Fondevila C; García-Valdecasas JC
    World J Surg; 2013 May; 37(5):1103-9. PubMed ID: 23389669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic usefulness of serum proteomic profile in hepatic colorectal metastases: a pilot prospective study.
    Martí J; Fuster J; Estanyol JM; Fernández F; Deulofeu R; Ferrer J; Pelegrina A; Reyes A; Fondevila C; García-Valdecasas JC
    Clin Transl Oncol; 2013 Sep; 15(9):691-7. PubMed ID: 23361307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implications of colorectal cancer molecular biology in clinical practice.
    Kargozaran H; Kahlenberg M; Khatri VP
    Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of colorectal cancer: new targets.
    Kitisin K; Mishra L
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S14-23. PubMed ID: 17178280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis.
    Arnold CN; Goel A; Blum HE; Boland CR
    Cancer; 2005 Nov; 104(10):2035-47. PubMed ID: 16206296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the chemoprevention of colorectal carcinoma.
    Gasche C
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.